Uni-Bio Science Secures Approval for Recombinant Collagen Class II Medical Device and Launches 肌顏態®: Pioneering Entry into the High-Growth Medical Aesthetics Market
The Group’s strategic cooperation product with Chongqing Minji Medical Device Co., Ltd., recombinant collagen dressing, has successfully received Class II medical device approval, with the approval number “渝械注准 20242140377”. At the same time, the Group’s self-developed medical aesthetics product, 肌顏態®, was successfully launched, marked by a grand event held in Wuhan.
The debut of肌顏態® has attracted high recognition and attention from many dermatologists and medical aesthetics practitioners.
These achievements reflect the Group’s strong commitment to innovation, strategic execution, and value creation. As the Group continues to execute its strategic vision, it remains focused on its goal of becoming China’s leading expert in dermatology, leveraging innovation, clinical expertise, and market insight to drive sustainable growth and long-term success.